DiaMedica Therapeutics, Inc. (DMAC)
8.42
-0.21
(-2.43%)
USD |
NASDAQ |
Oct 23, 10:26
DiaMedica Therapeutics Market Cap : 454.05M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 22, 2026 | 465.38M |
| October 21, 2026 | 468.61M |
| October 20, 2026 | 467.54M |
| October 19, 2026 | 424.40M |
| October 16, 2026 | 408.22M |
| October 15, 2026 | 433.56M |
| October 14, 2026 | 413.07M |
| October 13, 2026 | 421.70M |
| October 12, 2026 | 442.19M |
| October 09, 2026 | 449.20M |
| October 08, 2026 | 431.94M |
| October 07, 2026 | 430.87M |
| October 06, 2026 | 438.42M |
| October 05, 2026 | 454.05M |
| October 02, 2026 | 443.81M |
| October 01, 2026 | 450.28M |
| September 30, 2026 | 445.97M |
| September 29, 2026 | 442.19M |
| September 28, 2026 | 448.66M |
| September 25, 2026 | 428.17M |
| September 24, 2026 | 422.24M |
| September 23, 2026 | 407.68M |
| September 22, 2026 | 419.54M |
| September 21, 2026 | 391.50M |
| September 18, 2026 | 369.39M |
| Date | Value |
|---|---|
| September 17, 2026 | 369.39M |
| September 16, 2026 | 357.53M |
| September 15, 2026 | 352.13M |
| September 14, 2026 | 353.21M |
| September 11, 2026 | 348.90M |
| September 10, 2026 | 348.90M |
| September 09, 2026 | 355.37M |
| September 08, 2026 | 352.67M |
| September 04, 2026 | 364.00M |
| September 03, 2026 | 353.75M |
| September 02, 2026 | 364.00M |
| September 01, 2026 | 347.82M |
| August 31, 2026 | 342.43M |
| August 28, 2026 | 344.59M |
| August 27, 2026 | 364.00M |
| August 26, 2026 | 361.30M |
| August 25, 2026 | 363.46M |
| August 24, 2026 | 351.60M |
| August 21, 2026 | 351.60M |
| August 20, 2026 | 351.60M |
| August 19, 2026 | 367.23M |
| August 18, 2026 | 356.45M |
| August 17, 2026 | 356.99M |
| August 14, 2026 | 360.22M |
| August 13, 2026 | 364.00M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.403B |
| Alnylam Pharmaceuticals, Inc. | 29.93B |
| Anika Therapeutics, Inc. | 282.25M |
| Savara, Inc. | 866.79M |
| Vericel Corp. | 2.178B |
Market Cap Related Metrics
| PEG Ratio | -3.435 |
| Price to Book Value | 11.84 |
| Price | 8.42 |
| Earnings Yield | -8.48% |
| PEGY Ratio | -3.435 |